The global drug eluting stent market size is anticipated to reach around US$ 4,050 Mn by 2027 and growing at a CAGR of around 7% in terms of revenue during the forecast period 2020 to 2027.
A drug stent is filled with medication for time-disposal. It is pushed into the blood stream slowly to prevent it from being damaged again. According to research published in American Family Physician, about 40% of patients with angioplasticity or stent experience have restenosis. This means that the surgery of an artery is developing again. When done with a bare stent, this percentage decreases to about 30%. If a drug stent is used, it drops to less than 10%.
Market Insights
The drug eluting stent demand is largely motivated by a rise in the global geriatric population as they are extremely vulnerable to arterial disorders. Furthermore, the growing prevalence and occurrence of chronic atherosclerosis and obesity is likely to lead to the development of the medication eluting stent markets of the next century. For instance, according to the research conducted, more than 15.8 million people suffer from coronary artery disease, and nearly 8 million suffer from heart attacks. However, factors such as reduction in the drug-eluting stents pricing, and availability of alternative therapy procedure are the major obstacle to the growth of drug eluting stent market. Increasing preference for drugs over the surgical procedure of stent implants and increased risk of developing late-stage thrombosis are limiting the growth of drug-eluting stent market.
The increasing prevalence of chronic diseases like diabetes or heart attack is expected to fuel demand in the near future for drug eluting stents. The related advantages include a reduced risk of clotting the blood without affecting the endothelium. Consequently, they would be ideal for diabetic patients when introducing such products.
Report coverage
The market research study on “Drug Eluting Stent Market (By Drug: Sirolimus, Paclitaxel, Zotaroliums, Everoliums, Bioliums, Others; By Coating Type: Polymer Based Coating, Polymer Free Coatings; By Application: Coronary Artery Diseases, Peripheral Artery Diseases; By End-User: Cardiology Centers, Ambulatory Surgery Centers (ASCs), Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global drug eluting stent market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global drug eluting stent market are drug, coating type, application, end-user and major geographic regions. The drug eluting stent market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America accounts to hold large market share of global drug eluting stent market. The region is attributed to the stringent government regulations for manufacturing medical equipment and approval. Furthermore, the availability of reimbursement combined with a high rate of occurrence of heart disease is expected to improve the growth of North American market. In the projected period, the fastest development will occur in China, India, Brazil, and South Africa. In additional, patient awareness about the commercial supply of drugs, government financing, the continuous development of healthcare services and rising healthcare spending are the factors that lead to a substantial market growth in these country. Asia Pacific and Latin America is expected show a significant growth rate during forecast period 2020 - 2027. However, there has been steady growth throughout the projected period in the Middle East & Africa market.
Key Players
Key aspects such as the company's overview, product portfolio, financial perspective, current developments and competitive business strategies are the key players operating in the global drug elutting stent market. Major players operating in the market are Cook Medical, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Xtent, Inc., Medtronic plc, Johnson and Johnson, Stentys, MicroPort Scientific Corporation, Biotronik Inc., Biosensors International Group, and others.
The global drug eluting stent market is segmented as below:
Market Segmentation
Drug Eluting Stent Market By Drug
- Sirolimus
- Paclitaxel
- Zotaroliums
- Everoliums
- Bioliums
- Others
Drug Eluting Stent Market By Coating Type
- Polymer Based Coating
- Polymer Free Coatings
Drug Eluting Stent Market By Application
- Coronary Artery Diseases
- Peripheral Artery Diseases
Drug Eluting Stent Market By End-User
- Cardiology Centers
- Ambulatory Surgery Centers (ASCs)
- Hospitals
Drug Eluting Stent Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Drug Eluting Stent
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Drug Eluting Stent Market By Drug
1.2.2.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Drug (2016-2027)
1.2.2.2. Global Drug Eluting Stent Market Revenue Share By Drug in 2019
1.2.2.3. Sirolimus
1.2.2.4. Paclitaxel
1.2.2.5. Zotaroliums
1.2.2.6. Everoliums
1.2.2.7. Bioliums
1.2.2.8. Others
1.2.3. Drug Eluting Stent Market By Coating Type
1.2.3.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Coating Type (2016-2027)
1.2.3.1.1. Polymer Based Coating
1.2.3.1.2. Polymer Free Coatings
1.2.4. Drug Eluting Stent Market By Application
1.2.4.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Application (2016-2027)
1.2.4.2. Coronary Artery Diseases
1.2.4.3. Peripheral Artery Diseases
1.2.5. Drug Eluting Stent Market By End-User
1.2.5.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By End-User (2016-2027)
1.2.5.2. Cardiology Centers
1.2.5.3. Ambulatory Surgery Centers (ASCs)
1.2.5.4. Hospitals
1.2.6. Drug Eluting Stent Market By Geography
1.2.6.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.6.2. North America Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.3. Europe Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.4. Asia-Pacific Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.5. Latin America Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.6. Middle East and Africa (MEA) Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Drug Eluting Stent Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Drug Eluting Stent Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Drug Eluting Stent Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Drug Eluting Stent Major Manufacturers in 2019
CHAPTER 4. DRUG ELUTING STENT MARKET BY DRUG
4.1. Global Drug Eluting Stent Revenue By Drug
4.2. Sirolimus
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Paclitaxel
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Zotaroliums
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.5. Everoliums
4.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.6. Bioliums
4.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. DRUG ELUTING STENT MARKET BY COATING TYPE
5.1. Global Drug Eluting Stent Revenue By Coating Type
5.2. Polymer Based Coating
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Polymer Free Coatings
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 6. DRUG ELUTING STENT MARKET BY APPLICATION
6.1. Global Drug Eluting Stent Revenue By Application
6.2. Coronary Artery Diseases
6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Peripheral Artery Diseases
6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 7. DRUG ELUTING STENT MARKET BY END-USER
7.1. Global Drug Eluting Stent Revenue By End-User
7.2. Cardiology Centers
7.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.3. Ambulatory Surgery Centers (ASCs)
7.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.4. Hospitals
7.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 8. NORTH AMERICA DRUG ELUTING STENT MARKET BY COUNTRY
8.1. North America Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. North America Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. U.S.
8.3.1. U.S. Drug Eluting Stent Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 9. EUROPE DRUG ELUTING STENT MARKET BY COUNTRY
9.1. Europe Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Europe Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.6.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.7.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 10. ASIA-PACIFIC DRUG ELUTING STENT MARKET BY COUNTRY
10.1. Asia-Pacific Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Asia-Pacific Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.6.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.6.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.6.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.7.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.7.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.7.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.8.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.8.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.8.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 11. LATIN AMERICA DRUG ELUTING STENT MARKET BY COUNTRY
11.1. Latin America Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Latin America Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET BY COUNTRY
12.1. Middle East & Africa Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
12.2. Middle East & Africa Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Cook Medical
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abbott Laboratories
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Cordis Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Boston Scientific Corporation
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Xtent, Inc
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Medtronic plc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Johnson and Johnson
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Stentys
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. MicroPort Scientific Corporation
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Biotronik Inc
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Biosensors International Group
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
